If we are a drug and investment company so much the better but if we are left with BeaMed we won’t need staff or salaries and the outlook could still be very exciting.
I'm sure that investors in IPIX share your point of view about BeaMed. One look at the resumes of the co-founders is enough to be confidant that this is a winner.